Event Details
Pneumonia in the ImmunoCompromised: Use of the Karius Test® for the Detection of Undiagnosed Pathogens
The Karius Test® is a liquid biopsy for infection diseases that utilizes microbial cell-free DNA in plasma to detect over 1000 pathogens causing deep-seated and bloodstream infections. During his presentation Dr. Bergin will provide an overview of the Karius multi-center, prospective study comparing the Karius Test to Standard of Care in immunocompromised (IC) patients being evaluated for pneumonia. The population for this study are IC adults with hematological malignancies and/or hematocrit (HCT) with suspicion of pneumonia. Results are expected later in 2022.
*This program is sponsored by Karius and CME credit is not available for this event.
Speaker
Stephen P Bergin, MD
Assistant Professor of Medicine
Director, Fellowship Training Programs
Pulmonary and Critical Care Medicine
Duke University Health System
About the Karius Test
The Karius Test is a liquid biopsy needing only a single blood sample to rapidly and non-invasively detect over 1,000 pathogens causing deep-seated and bloodstream infections.
1 blood sample
.svg)
1-day processing
.svg)
1000+ pathogens